Principal treatment-related toxicities that come from amivantamab administration include skin-related reactions, higher risk of venous thrombolism, and infusion-related reactions. With numerous ...
The COCOON trial assessed prophylactic dermatologic regimens in NSCLC patients treated with amivantamab and lazertinib, showing reduced AEs and improved quality of life. Prophylactic treatment ...
The COCOON regimen significantly reduced dermatologic side effects and improved quality of life in EGFR-mutated NSCLC patients treated with amivantamab and lazertinib. Patients receiving COCOON DM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results